Jubilant Generics Limited

Jubilant Life Sciences Limited

Sujay Biswas

Dharam Vir

Mukesh Masand

Vikas Bansal

Rajendra Shekhawat

Rajesh Kumar

Indranil Nandi

Amit Srivastava

Shailendra Kumar Dubey

Anjul Kumar

Mokkapati Umamaheshwar Prasad

Lalit Kumar

Rakesh Tiwari

Jai Prakash Verma

Atulya Kumar Panda

Sanjeev Kumar

Danish Jamshad

Bidyut Biswas

Sankareswaran Srimurugan

Rohit Chakravarty

Brijesh Kumar Shukla

Ashish Kumar Gupta

Khushwant Singh

Nirmal Kumar

Ratnakar Tripathi

Rajendra Singh Shekhawat

Amit Kumar Srivastava

The invention relates to a commercially viable, cost effective and energy efficient process for the preparation of 2-(1H-Imidazol-4-yl)ethanamine or pharmaceutically acceptable salts thereof in high purity and yield via application of continuous flow technology.

Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof

The present invention provides an improved process for the preparation of exametazime, which is used as ligand in preparation of technetium-99m complex. 

Process for the preparation of exametazime

The present invention relates to an improved process for the preparation of Apixaban and intermediates thereof. Further the present invention also relates to novel intermediate of Formula V and its process for the preparation.

Process for the preparation of apixaban and intermediates thereof

The present invention provides a novel process for the preparation of substituted optically pure (S)-(+)- or (R)-(&#x2212;)-10-hydroxy-dihydrodibenz[b,f]azepines or derivatives thereof, starting from 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepines using boronate esters or their derivatives. The present invention also provides use of thus prepared (S)-(+)- or (R)-(&#x2212;)-10-hydroxy-dihydrodibenz[b,f]azepines for the preparation of their ester such as (S)-(&#x2212;)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide or (R)-(+)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide. The present invention also provides novel solid state crystalline forms J, J, J, Jand amorphous form of eslicarbazepine and the process for the preparation thereof. Also, the present invention provides novel solid state crystalline form and amorphous form of eslicarbazepine acetate and the process for the preparation thereof. The novel solid state forms of eslicarbazepine are useful for the preparation of derivatives of eslicarbazepine such as eslicarbazepine acetate.

Process for the preparation of (S)-(+)- or (R)-(-)-10-hydroxy dihydrodibenz[B,F]azepines by enantioselective reduction of 10,11-dihydro-10-OXO-5H-dibenz[B,F]azepines and polymorphs thereof

The present invention provides a novel process and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren, or a salt thereof, preferably Aliskiren hemifumarate.

Process for the preparation of aliskiren

Growing community of inventors

Noida, India

Sujay Biswas